Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
N/A
58 Added 26.24%
279 $0
Q1 2024

Nov 05, 2024

SELL
N/A
-58 Reduced 20.79%
221 $0
Q1 2024

May 15, 2024

BUY
N/A
90 Added 68.7%
221 $0
Q4 2023

Feb 14, 2024

SELL
N/A
-6 Reduced 4.38%
131 $0
Q3 2023

Nov 14, 2023

SELL
N/A
-341 Reduced 71.34%
137 $0
Q2 2023

Aug 14, 2023

BUY
N/A
478 New
478 $0
Q3 2022

Nov 14, 2022

BUY
$1.29 - $2.52 $942 - $1,842
731 Added 31.07%
3,084 $4,000
Q2 2022

Aug 15, 2022

BUY
$2.22 - $6.7 $2,215 - $6,686
998 Added 73.65%
2,353 $5,000
Q1 2022

May 16, 2022

SELL
$4.18 - $13.39 $14,684 - $47,039
-3,513 Reduced 72.17%
1,355 $9,000
Q4 2021

Feb 14, 2022

BUY
$11.35 - $97.17 $35,150 - $300,935
3,097 Added 174.87%
4,868 $61,000
Q3 2021

Nov 15, 2021

SELL
$52.0 - $120.21 $238,888 - $552,244
-4,594 Reduced 72.18%
1,771 $162,000
Q2 2021

Aug 16, 2021

BUY
$31.88 - $58.66 $202,916 - $373,370
6,365 New
6,365 $337,000

Others Institutions Holding CRTX

About Cortexyme, Inc.


  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.